Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

Bankrupt genetic testing company 23andMe has been sold to Regeneron Pharmaceuticals for $256 million. The deal includes ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025" has been added to ResearchAndMarkets.com's offering. This report contains a ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

The biotech is fighting to preserve its cash while continuing to push its key cancer treatment through clinical trials. HHS ...

Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy ...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. The report contains a ...

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at where Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stands against other best ...

Purdue University's College of Pharmacy has partnered with Stony Brook University to bring the Center for Research Innovation in Biotechnology and its Clinical Drug Experience Knowledgebase to the ...